Enzolytics (ENZC) News Today $0.0010 0.00 (0.00%) (As of 11/21/2024 ET) Add Compare Share Share Headlines Stock AnalysisChartShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Enzolytics, Inc. (ENZC)April 19, 2024 | finance.yahoo.comEnzolytics, Inc.: Update on Formulation of New Business StrategyApril 12, 2024 | finanznachrichten.deENZOLYTICS, INC. SHAREHOLDERS HOLD SPECIAL MEETING AND ELECT NEW BOARDMarch 25, 2024 | finance.yahoo.comEnzolytics Stock (OTC:ENZC) Insider TradesFebruary 26, 2024 | benzinga.comEnzolytics Stock (OTC:ENZC) Earnings Dates and Earning CallsFebruary 22, 2024 | benzinga.comEnzolytics, Inc. Announces Partnership With the Khalpey AI Lab To Forge the Future of Multi-Organ Remodeling and Rejuvenation With a Strategic Focus on LongevityJanuary 16, 2024 | finance.yahoo.comEnzolytics Inc ENZCNovember 11, 2023 | morningstar.com"Exploring Penny Stocks: Four Watchlist Options" FTRS, ELTP, ENZC, ZOMOctober 31, 2023 | benzinga.comEnzolytics Announces the Signing of the Business Combination Agreement with Sagaliam Acquisition Corp (SAGA)September 18, 2023 | finance.yahoo.comPatient Population for the Clinical Trials of ITV-1 has been Established by the European Medicines Agency ("EMA")September 6, 2023 | finance.yahoo.comBiogenysis, Inc. Announces Partnering with Khalpey AI Lab and Contenta, Ltd. to Incorporate AI in Microbiome Analysis to Identify Biomarkers for Use in Accurately Predicting Alzheimer's Disease Onset and Prevention.September 5, 2023 | finance.yahoo.comBiogenysis’ International Patent Application, Covering Its Anti-SARS-CoV-2 Monoclonal Antibodies, Advances to Prosecution in Europe and as a U.S. National Stage Application.August 24, 2023 | finance.yahoo.comVirogentics, Inc. Receives Permit for Export to Africa of the ITV-1 Immunotherapy Solidifying the Scheduled Administration of the TreatmentAugust 8, 2023 | finance.yahoo.comVirogentics, Inc. Provides Update on African Project, European Medicine Agency Application and Clinical Trials for Application for Type 2 DiabetesAugust 4, 2023 | finance.yahoo.comOTC Stocks to Watch in August 2023: HNRC, BDPT, ENZC, AABB, SNNCJuly 28, 2023 | benzinga.comEnzolytics, Inc.: Virogentics Announces Approval of Final Protocol from the Dept for HIV and AIDS, Ministry of Health of the DRCJuly 25, 2023 | finanznachrichten.deBiogenysis Inc. Announces a Collaboration with Khalpey AI Lab in using Artificial Intelligence (AI) for Unveiling Potential Biomarkers and Predicting the Onset or Prevention of Alzheimer's Disease.July 21, 2023 | finance.yahoo.comEnzolytics, Inc.: Virogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 And Diabetic Clinical TrialsJuly 6, 2023 | finanznachrichten.deVirogentics, Inc to Introduce a Dietary Supplement Offers Additional Information on ITV-1 And Diabetic Clinical TrialsJuly 6, 2023 | finance.yahoo.comEnzolytics Offers Update on Virogentics, Inc ITV-1 African ProjectJune 26, 2023 | finance.yahoo.comENZC - Enzolytics, Inc.June 11, 2023 | sg.finance.yahoo.comEnzolytics Offers Update on Virogentics and Sale Transaction, Clinical Trials Progress on European Medicine Agency (EMA) Permitting and Arican ITV-1 ProjectJune 5, 2023 | finance.yahoo.comVirogentics and Enzolytics Refute Misleading Information Being Circulated on Social Media and Other Internet Outlets Biogenesis to be Featured in June Issue of Life Science ReviewMay 19, 2023 | finance.yahoo.comEnzolytics, Inc.: Virogentics Inc. Receives Report from Bulgarian Academy of Sciences Administration of ITV-1 to Begin First Week in June 2023May 16, 2023 | finanznachrichten.deVirogentics Inc. Receives Report from Bulgarian Academy of Sciences Administration of ITV-1 to Begin First Week in June 2023May 16, 2023 | finance.yahoo.comOTC Stocks Making Waves: Recent Developments and Potential Opportunities (HBRM, BBRW, ENZC, SIRC)May 12, 2023 | benzinga.comVirogentics Inc. Announces Pilot Clinical Trial of ITV-1 at National Center for Endocrinology in Bulgaria and Expansion of Nutraceutical LineMay 8, 2023 | finance.yahoo.comEnzolytics Inc. Continues Progress with Business Combination; Biogenysis Announces Team and Plans for SuccessApril 27, 2023 | finance.yahoo.comEnzolytics, Inc. Finalizing Regulatory Labeling Requirements for Delivery of ITV-1 Treatments for Use in Hospitals in Central and Eastern Africa - Company also Provides Additional Details on the Sale of Biogenysis and VirogenticsApril 21, 2023 | finance.yahoo.comEnzolytics Inc. (ENZC)April 18, 2023 | ca.finance.yahoo.comEnzolytics, Inc. Announces Execution of Non-Binding Term Sheet with the Special Purpose Acquisition Company Sagaliam Acquisition Corp. and Updates the Progress on the African ProjectApril 17, 2023 | finance.yahoo.comEnzolytics Announces Progress in the Development and Patenting of Feline Leukemia Monoclonal AntibodiesApril 4, 2023 | finance.yahoo.comEnzolytics Stock (OTC:ENZC), DividendsMarch 3, 2023 | benzinga.comEnzolytics, Inc. Highlights Plans for Promotion of IPF Immune(TM), Its Patented Nutraceutical SupplementFebruary 28, 2023 | finance.yahoo.comEnzolytics Announces Preliminary Results of GLP Toxicology Study for its anti-HIV Therapeutic ITV-1 and Production of ITV-1 for Initiation of Registration in AfricaFebruary 8, 2023 | finance.yahoo.comEnzolytics to Develop Feline Monoclonal AntibodiesJanuary 3, 2023 | finance.yahoo.comEnzolytics, Inc. Announces the Completion of the 2020 and 2021 Audited FinancialsDecember 19, 2022 | finance.yahoo.comEnzolytics Recognizes World AIDS Day and Highlights the Company's Focus on Producing Effective Therapies for Treating HIVDecember 1, 2022 | finance.yahoo.comEnzolytics, Inc. Announces Expansion of Production of Its Monoclonal Antibody Therapeutics and Marketing of IPF Immune(TM)November 16, 2022 | finance.yahoo.comEnzolytics Reports Successful Completion of an MTD Tolerability Study of Its ITV-1 anti-HIV Therapeutic Leading to the Start of a 28-day GLP Toxicology StudyOctober 5, 2022 | finance.yahoo.comEnzolytics Inc. Announces Collaboration with Abveris to Discover Monoclonal AntibodiesSeptember 16, 2022 | finance.yahoo.comEnzolytics Inc. Announces Litigation Success, Accounting Progress and Removal of "Yield" Sign on OTC Markets Stock QuotesSeptember 14, 2022 | finance.yahoo.comENZC.PK - Enzolytics Inc | Stock Price & Latest News | ReutersAugust 14, 2022 | reuters.comEnzolytics Announces the International Patent Office Search Report finding Novelty and Inventiveness in the Company's Pending International Patent Application Covering its anti-HIV Monoclonal Antibodies.July 28, 2022 | finance.yahoo.com2022-06-21 | OTCPK:ENZC | Press Release | Enzolytics Inc - StockhouseJune 21, 2022 | stockhouse.comEnzolytics Announces the Discovery of Conserved Target Sites on the Monkeypox VirusJune 21, 2022 | finance.yahoo.com2022-05-16 | OTCPK:ENZC | Press Release | Enzolytics Inc - StockhouseMay 17, 2022 | stockhouse.comEnzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day PodcastMay 16, 2022 | finance.yahoo.comCORRECTION: Enzolytics, Inc. Reports Progress and Future PlansApril 25, 2022 | finanznachrichten.deEnzolytics, Inc.: Enzolytics IPF Immune Introduced to Large and Small Retail Buyers at Recent ECRM "Weight Management, Nutrition, and Vitamin Program"April 11, 2022 | finanznachrichten.de Get Enzolytics News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZC and its competitors with MarketBeat's FREE daily newsletter. Email Address When it comes to NVDA… “acceleration cycles” are the key (Ad)Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again. Use this link to see Nvidia Unchained right away! ENZC Media Mentions By Week ENZC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ENZC News Sentiment▼0.000.48▲Average Medical News Sentiment ENZC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ENZC Articles This Week▼00▲ENZC Articles Average Week Get Enzolytics News Delivered to You Automatically Sign up to receive the latest news and ratings for ENZC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Bravo Multinational News Entain News Fearless Films News Hall of Fame Resort & Entertainment News InCapta News Lingerie Fighting Championships News Table Trac News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ENZC) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Enzolytics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Enzolytics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
